Antiviral therapy with the hepatitis B immunoglobulin (HBIG) was carried out in 11 patients (10.1%) due to a replicative hepatitis B infection or for hepatitis B positive donor organ (n = 4). The gene discussed is PPIB; the disease is hepatitis B virus infection.